insights_auto
Why is IONS down 2,35%?
Dive Deeperchevron_right
IONS:NASDAQ
Ionis Pharmaceuticals Inc
26,58 USD
arrow_downward
-2,35%(-0,64) 1D
26,85 USD
arrow_upward
+1,02% (+0,27)bedtimeAfter hours
Closed: 20-ноя., 16:00:02 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for IONS...
Open
26,92 USD
High
28,07 USD
Low
26,53 USD
Mkt. cap
4,43 млд
Avg. vol.
4,13 млн
Volume
3,19 млн
52-wk high
86,74 USD
52-wk low
26,53 USD
EPS
-3,33 USD
Beta
0,43
Shares outstanding
166,54 млн
No. of employees
1 миң
Open
26,92 USD
High
28,07 USD
Low
26,53 USD
Mkt. cap
4,43 млд
Avg. vol.
4,13 млн
Volume
3,19 млн
52-wk high
86,74 USD
52-wk low
26,53 USD
EPS
-3,33 USD
Beta
0,43
Shares outstanding
166,54 млн
No. of employees
1 миң
News stories
From web sources and news partners
Investing.com
·
1 саат мурун
Ionis Pharmaceuticals stock hits 52-week low at 26.54 USD
Zacks Investment Research
·
2 күн мурун
Ionis' Tryngolza Gets EU Approval for Severe Hypertriglyceridemia
Zacks
·
2 күн мурун
Ionis' Tryngolza Gets EU Approval for Severe Hypertriglyceridemia
Benzinga
·
2 күн мурун
Biogen Reports Two-Year Data Showing Diranersen Slows Early Alzheimer's Decline
Profile
Ionis Pharmaceuticals, Inc. is a biotechnology company that specializes in discovering and developing antisense therapy, as well as RNA interference and CRISPR therapeutics. The company was founded in 1989 is based in Carlsbad, California. The company was previously known as Isis Pharmaceuticals until December 2015. Wikipedia
About Ionis Pharmaceuticals Inc
CEOBrett P. Monia Ph.D.
Employees1,48 миң
Founded1989
HeadquartersКарлсбад, Калифорния, Америка Кошмо Штаттары
SectorHealth Care
Industry-
Websiteionis.com